Literature DB >> 8112255

Focal cerebral magnetic resonance changes associated with partial status epilepticus.

T R Henry1, I Drury, J A Brunberg, P B Pennell, P E McKeever, A Beydoun.   

Abstract

We report 2 patients with transient abnormalities on magnetic resonance imaging (MRI) associated with partial status epilepticus (SE). A man with a 4-month history of partial seizures had complex partial SE for 9 days, with left temporal maximum on ictal EEG. Left temporal lobe T2 signal was increased on MRI during SE, but cerebral MRI was normal 9 weeks later. A woman with "cryptogenic" temporal lobe epilepsy for 16 years had complex partial SE for 1 week, with right temporal maximum on ictal EEG. T2 Signal was increased over the entire right temporal lobe, extending into the insula, without mass effect, on MRI 1 month after SE ended. Repeat MRI 1 month later showed marked decrease in volume of increased T2 intensity, without gadolinium enhancement, but with mild mass effect over the right anterioinferomesial temporal areas. A gemistocytic astrocytoma was resected. Focal cerebral MRI abnormalities consistent with cerebral edema may be due to partial SE but also may indicate underlying glioma, even in long-standing partial epilepsy. Focal structural imaging changes consistent with neoplasm should be followed to full resolution after partial SE.

Entities:  

Mesh:

Year:  1994        PMID: 8112255     DOI: 10.1111/j.1528-1157.1994.tb02909.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  14 in total

1.  Focal transient lesion in the splenium of the corpus callosum in three non-epileptic patients.

Authors:  Antônio José da Rocha; Fabiano Reis; Hugo Pereira Pinto Gama; Carlos Jorge da Silva; Flávio Túlio Braga; Antônio Carlos Martins Maia; Fernando Cendes
Journal:  Neuroradiology       Date:  2006-08-30       Impact factor: 2.804

2.  Changes on diffusion-weighted MRI with focal motor status epilepticus: case report.

Authors:  P Senn; K O Lövblad; D Zutter; C Bassetti; O Zeller; F Donati; G Schroth
Journal:  Neuroradiology       Date:  2003-02-25       Impact factor: 2.804

3.  Severe transitory encephalopathy with reversible lesions of the claustrum.

Authors:  J Sperner; B Sander; S Lau; H Krude; D Scheffner
Journal:  Pediatr Radiol       Date:  1996-11

4.  Transient MR signal changes in patients with generalized tonicoclonic seizure or status epilepticus: periictal diffusion-weighted imaging.

Authors:  J A Kim; J I Chung; P H Yoon; D I Kim; T S Chung; E J Kim; E K Jeong
Journal:  AJNR Am J Neuroradiol       Date:  2001 Jun-Jul       Impact factor: 3.825

5.  Prolonged deficits after focal inhibitory seizures.

Authors:  Miguel Bussière; David Pelz; Robert H Reid; G Bryan Young
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

6.  Transient lesion in the splenium of the corpus callosum: three further cases in epileptic patients and a pathophysiological hypothesis.

Authors:  T Polster; M Hoppe; A Ebner
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-04       Impact factor: 10.154

7.  Thalamus lesions in chronic and acute seizure disorders.

Authors:  Henriette J Tschampa; Susanne Greschus; Robert Sassen; Christian G Bien; Horst Urbach
Journal:  Neuroradiology       Date:  2010-06-29       Impact factor: 2.804

8.  [Postictal MR-changes. A rare and important differential diagnosis].

Authors:  E Hattingen; P Raab; H Lanfermann; F E Zanella; S Weidauer
Journal:  Radiologe       Date:  2008-11       Impact factor: 0.635

Review 9.  1H MR spectroscopy in patients with mesial temporal epilepsy.

Authors:  M Hájek; M Dezortová; V Komárek
Journal:  MAGMA       Date:  1998-12       Impact factor: 2.310

Review 10.  Calcific neurocysticercosis and epileptogenesis.

Authors:  T E Nash; O H Del Brutto; J A Butman; T Corona; A Delgado-Escueta; R M Duron; C A W Evans; R H Gilman; A E Gonzalez; J A Loeb; M T Medina; S Pietsch-Escueta; E J Pretell; O M Takayanagui; W Theodore; V C W Tsang; H H Garcia
Journal:  Neurology       Date:  2004-06-08       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.